Literature DB >> 18980448

Rare bone metastases of the olecranon.

Shaelyn Culleton1, Eric de Sa, Monique Christakis, Michael Ford, Ingrid Zbieranowski, Emily Sinclair, Patrick Cheung, Sarah Campos, Philiz Goh, Edward Chow.   

Abstract

Abstract Bone metastases are prevalent in patients with cancer, especially with primary lung, breast, renal cell, thyroid, and prostate carcinomas. When looking specifically at primary renal cell carcinoma, approximately 40% of patients will develop bone metastases during the course of their disease. However, distal bony involvement to the appendicular skeleton occurs less frequently, developing below the elbow and knee in approximately 7% of metastatic renal cell carcinoma patients. The incidence of olecranon metastasis is extremely rare in all cancers and so far only two cases have been reported in literature. We report the third case of an olecranon metastasis in a patient with renal cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18980448     DOI: 10.1089/jpm.2008.0085

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  3 in total

1.  Rare Giant Cell Tumor of Olecranon Bone!!!!

Authors:  Pawan Goyal; Vishal Gautam; Narender Saini; Yogesh Sharma
Journal:  J Orthop Case Rep       Date:  2016 Sep-Oct

2.  Rare giant cell tumor involvement of the olecranon bone.

Authors:  Chen Yang; Yubao Gong; Jianguo Liu; Xin Qi
Journal:  J Res Med Sci       Date:  2014-06       Impact factor: 1.852

Review 3.  Olecranon metastases from primary lung cancer: case report and review of the literature.

Authors:  Leyi Cai; Shuangxia Dong; Hua Chen
Journal:  J Int Med Res       Date:  2019-09-23       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.